Sickles E A
Breast Imaging Section, University of California School of Medicine, San Francisco 94143.
Clin Imaging. 1991 Oct-Dec;15(4):253-60. doi: 10.1016/0899-7071(91)90113-a.
Mammography is generally accepted as a useful problem-solving clinical tool in characterizing known breast lesions, so that appropriate and timely treatment can be given. However, it remains grossly underutilized at what it does best: screening. The major strengths of mammography are a) its ability to detect breast cancer at a smaller, potentially more curable stage than any other examination, and b) its proved efficacy in reducing breast cancer mortality in asymptomatic women aged 40-74. If, as has recently been estimated, screening with mammography and physical examination can be expected to lower breast cancer deaths by 40%-50% among those actually examined (13), then the lives of almost 20,000 U.S. women might be saved each year if screening were to become very widely used. The challenges of the next decade are clear, to mount much more effective campaigns to educate physicians and lay women about the life-saving benefits of breast cancer screening, to devise increasingly effective and lower cost screening strategies, to further improve the current high quality of mammographic imaging despite its increasing proliferation, and to train large numbers of breast imaging specialists to guarantee that the growing case load of screening and problem-solving mammograms is interpreted with a very high level of skill.
乳腺钼靶摄影术通常被认为是一种有用的临床问题解决工具,可用于对已知乳腺病变进行特征描述,从而能够给予适当且及时的治疗。然而,在其最擅长的筛查方面,它仍未得到充分利用。乳腺钼靶摄影术的主要优势在于:a)与其他任何检查相比,它能够在乳腺癌处于较小、可能更易治愈的阶段时检测到;b)在40至74岁无症状女性中,其在降低乳腺癌死亡率方面已被证实具有疗效。如果像最近估计的那样,通过乳腺钼靶摄影术和体格检查进行筛查有望使实际接受检查者中的乳腺癌死亡人数降低40%至50%(13),那么如果筛查得到广泛应用,每年可能挽救近20000名美国女性的生命。未来十年面临的挑战很明确,即开展更有效的宣传活动,向医生和普通女性普及乳腺癌筛查的救命益处,设计出越来越有效且成本更低的筛查策略,尽管乳腺钼靶成像数量不断增加,但仍要进一步提高当前的高质量成像水平,并培训大量乳腺影像专家,以确保对日益增多的筛查和解决问题的乳腺钼靶照片进行高水平的解读。